Imunon, Inc. (IMNN) vs Traws Pharma, Inc. (TRAW)
- Imunon, Inc. IMNN 1.02 −3.77%
- Traws Pharma, Inc. TRAW 0.37 −7.50%
Imunon, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Imunon, Inc. and Traws Pharma, Inc. are of similar size ($6.2M and $6.0M). Traws Pharma, Inc. grew revenue faster over the last twelve months: 1,159.3% against 0.00%. Across the 15 metrics below, Traws Pharma, Inc. leads on 11 and Imunon, Inc. on 4.
Valuation
Profitability
| Metric | IMNN | TRAW | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (641.02%) | (319.42%) | (56.36%) |
| Return on assets | (123.93%) | (117.35%) | (48.04%) |
| Return on invested capital | (324.37%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack